The lack of information can leave potential users feeling uncertain about its safety
They are complementary tools
Intramuscular replacement therapy is indicated for patients with: Significant B12 deficiency (thresholds depend on local laboratory reference ranges) Neurological symptoms or signs Pernicious anaemia Malabsorption syndromes The standard UK regimen for patients without neurological involvement involves hydroxocobalamin 1mg intramuscularly three times weekly for two weeks, followed by maintenance injections every 2-3 months (often 3-monthly)
White blood cells gather at an injury site and fight infections by attacking bacteria, viruses, or germs
This category groups the reconstitution and handling materials researchers use alongside peptide compounds
often continued for several weeks Should be administered by a healthcare professional Side Effects Pain or redness at the injection site Mild nausea, dizziness, or headache Rare allergic reactions (rash, itching, swelling) Hypokalemia in cases of rapid anemia correction Contraindications Known hypersensitivity to Methylcobalamin or cobalt Lebers disease (hereditary optic neuropathy) Caution in patients with renal dysfunction or folate deficiency Availability Methylcobalamin 500 mcg injection Vitamin B12 injection for nerve health Injectable B12 for anemia Methylcobalamin IM 1ml dose Nerve vitamin injection Vitamin B12 deficiency treatment